“Subclinical Left Ventricular Dysfunction Prevention in Breast Cancer Patients After FAC Chemotherapy: A Carvedilol Trial”. International Journal of Integrated Health Sciences, vol. 12, no. 1, Mar. 2024, pp. 55-64, https://doi.org/10.15850/ijihs.v12.n1.3570.